A complicated neurological disease known as autism spectrum disorder (ASD) is typified by issues with social interaction, communication, and repetitive behavior. The neural protective mechanisms in ASD are thought to be influenced by genetic variables, including the expression of neurotrophic genes such as glial cell line-derived neurotrophic factor (GDNF). The aim was to examine the relationship between neuronal protection and cognitive functioning by crosslinking GDNF gene expression and serum levels in individuals with relation to Mini-Mental State Examination (MMSE) scores in ASD patients. After getting study approval and informed consent of patients, this case-control study experimental study was conducted for six months between July 2023 and December 2023. The blood samples (5 ml each) were drawn from the study population (n = 140), including 100 ASD patients with a disease course of30 months based on patients' reports data and 40 healthy controls from four major clinical and hospital settings in Lahore, Karachi, and Bahawalpur from Pakistan. The analytical procedures included nucleic acid extraction, primer design and optimization, and GDNF-targeted real-time quantitative polymerase chain reaction expression analysis. To measure cognitive and behavioral deficits, enzyme-linked immunosorbent assay-based serum GDNF levels (pg/ml) and MMSE scores were compared, concluding the neuronal protection potential of GDNF. In patients with ASD, lower serum levels of GDNF (9.371 ± 2.388 pg/ml) were linked to more severe behavioral and cognitive deficits confirmed by MMSE scores (13.6 ± 3.5) of ASD patients in comparison with the control group (27.1 ± 2.1). Healthy individuals showed higher relative gene fold expression (11.71) compared to the ASD patients (5.51). There is a notable decrease in GDNF gene expression in people with ASD, which raises the possibility that GDNF is important for both cognitive performance and neuronal protection in these people. GDNF may be a useful biomarker for identifying ASD and comprehending its molecular causes, opening the door for focused treatment approaches.
Read full abstract